- Home
- FGI vs SBFM Comparison
FGI vs SBFM Comparison
Compare FGI & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- SBFM
- Stock Information
- Founded
- FGI 1987
- SBFM 2006
- Country
- FGI United States
- SBFM United States
- Employees
- FGI N/A
- SBFM N/A
- Industry
- FGI Industrial Specialties
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- SBFM Health Care
- Exchange
- FGI Nasdaq
- SBFM Nasdaq
- Market Cap
- FGI 7.7M
- SBFM 3.7M
- IPO Year
- FGI 2022
- SBFM N/A
- Fundamental
- Price
- FGI $0.91
- SBFM $3.06
- Analyst Decision
- FGI
- SBFM
- Analyst Count
- FGI 0
- SBFM 0
- Target Price
- FGI N/A
- SBFM N/A
- AVG Volume (30 Days)
- FGI 8.5K
- SBFM 121.6K
- Earning Date
- FGI 11-06-2024
- SBFM 11-11-2024
- Dividend Yield
- FGI N/A
- SBFM N/A
- EPS Growth
- FGI N/A
- SBFM N/A
- EPS
- FGI 0.06
- SBFM N/A
- Revenue
- FGI $121,013,893.00
- SBFM $30,481,982.00
- Revenue This Year
- FGI $5.53
- SBFM $86.70
- Revenue Next Year
- FGI $5.05
- SBFM $126.76
- P/E Ratio
- FGI $15.19
- SBFM N/A
- Revenue Growth
- FGI N/A
- SBFM 109.82
- 52 Week Low
- FGI $0.70
- SBFM $2.42
- 52 Week High
- FGI $1.85
- SBFM $660.00
- Technical
- Relative Strength Index (RSI)
- FGI 62.84
- SBFM 49.32
- Support Level
- FGI $0.74
- SBFM $2.85
- Resistance Level
- FGI $0.99
- SBFM $3.05
- Average True Range (ATR)
- FGI 0.05
- SBFM 0.15
- MACD
- FGI 0.02
- SBFM 0.02
- Stochastic Oscillator
- FGI 71.43
- SBFM 63.89
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.